Aurobindo Pharma to acquire firm in Italy
Aurobindo Pharma Ltd said on Monday it has concluded a deal to acquire Italy's Intellectual Property & Marketing Authorizations.
This strategic acquisition would jump-start the business for Aurobindo in Italy where the market and the regulatory procedures are considered as one of the toughest in the European Union, it said in a statement.
No financial details were immediately available. Shares in the company were up 3 percent at 256 rupees in a firm Mumbai market.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.